Member - Holopharm

Holopharm is a research and development company for innovative solutions in the fields of chemistry, health and energy.

Type Startup or self-employed
Founded 2016
Company Size 7
Member Type
Founders Pierre-marie Mondin & Julien MORVAN
Headquarters 27000 Évreux, France
Social network


Holopharm is a young company specializing in pharmaceutical research (development of formulations and analyzes). Holopharm is also working on the depollution of toxic organic products from industrial effluents. In this context, Holopharm has developed a technology by electrochemical treatment to purify polluted water. This technology is part of a new patent that can also be used in the desalination of seawater. The technology also makes it possible to produce dry steam instantly with an exceptional efficiency close to 100%.
Headquarters 27000 Évreux, France

SDG’s of application

The Sustainable Development Goals are a call to action to end poverty, protect the planet and ensure peace and prosperity everywhere.
Clean water and sanitation
SDG 6 icon
Affordable and clean energy
SDG 7 icon
Industry, innovation and infrastructure
SDG 9 icon
SDG 11
Sustainable cities and communities
SDG 11 icon
SDG 12
Responsible consumption and production
SDG 12 icon

The information set out above, is solely for the purposes of information and the Solar Impulse Foundation does not provide any guarantee as to its authenticity, completeness or accuracy. To validate the Membership to the World Alliance for Efficient Solutions, the Solar Impulse Foundation only verifies that each entity is registered and has signed our principles and values stated in the following World Alliance for Efficient Solutions charter. For those Members who are also solution providers, this information does not constitute investment advice or a recommendation to buy into, transact or to enter into any agreement with any of the parties or persons mentioned above. Potential investors or interested parties are solely responsible for their investment or business decisions and for performing any due diligence required by the circumstances.